Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111550 · ClinicalTrials.gov registry record · NA
Clinical Investigation of the Next-Generation Intraocular Lens
A NA study, sponsored by Abbott Medical Optics.
- Completed
- Registry status
- NA
- Development phase
- 242
- Enrollment target
NCT03111550: Completed NA study, sponsored by Abbott Medical Optics.
NCT03111550 is a NA study that has completed, run by Abbott Medical Optics. The registered enrollment target is 242 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03111550, a NA study, has completed, sponsored by Abbott Medical Optics.
- COMPLETED
- Registry status
- NA
- Development phase
- 242 participants
- Enrollment target
Study Summary
This study is a 6-month, prospective, multicenter, bilateral, randomized clinical investigation of the TECNIS Model ZHR00 and Model ZQR00 IOLs versus the TECNIS Symfony control IOL. The study was conducted at 12 sites in the U.S.A and treated approximately 240 subjects, equally split between the two test groups and the control group.
Primary Outcome
The primary effectiveness endpoint is mean (LogMAR), photopic, monocular, first-eye, distance corrected near visual acuity (40 cm) at 1 month postoperative
Interventions
- DEVICE Investigational Intraocular Lens Device #1: TECNIS Model ZHR00
- DEVICE Investigational Intraocular Lens Device #2: TECNIS Model ZQR00
- DEVICE TECNIS Symfony® Extended Range of Vision Intraocular Lens: Model ZXR00
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2017-05-10 |
| Est. Completion | 2018-02-23 |
| Phase | NA |
What the finished NCT03111550 record still lists
NCT03111550 is an interventional study that assigns participants to a tested intervention. The registered 242 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 3 interventions - of which Investigational Intraocular Lens Device #1: TECNIS Model ZHR00 is the first listed.
NCT03111550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03111550 about?
NCT03111550 is a clinical study titled "Clinical Investigation of the Next-Generation Intraocular Lens". This study is a 6-month, prospective, multicenter, bilateral, randomized clinical investigation of the TECNIS Model ZHR00 and Model ZQR00 IOLs versus the TECNIS Symfony control IOL. The study was conducted at 12 sites in the U.S.A and treated approximately 240 subjects, equally split between the tw...
What is the current status of trial NCT03111550?
This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2017-05-10. Estimated completion is 2018-02-23.
What interventions are being tested in trial NCT03111550?
The interventions under investigation include: Investigational Intraocular Lens Device #1: TECNIS Model ZHR00 (DEVICE), Investigational Intraocular Lens Device #2: TECNIS Model ZQR00 (DEVICE), TECNIS Symfony® Extended Range of Vision Intraocular Lens: Model ZXR00 (DEVICE).
Who is sponsoring clinical trial NCT03111550?
This trial is sponsored by Abbott Medical Optics, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03111550's enrollment target sits among peer trials
242 439th of 2000 higher than 1,561 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03556228 · 242 participants · Phase 1
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- NCT04260022 · 242 participants · Phase 1
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- NCT04459000 · 242 participants · NA
Substance Use Treatment and Access to Resources (STARS) Project
- NCT05644496 · 242 participants · Phase 4
ZYNRELEF for Pain Management in Total Knee Arthroplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI